Stempoint Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-15,415
Closed -$3.77M 99
2026
Q1
$3.77M Sell
15,415
-19,585
-56% -$4.56M 0.72% 42
2025
Q4
$7.24M Buy
+35,000
New +$6.92M 1.24% 23
2024
Q1
Sell
-61,011
Closed -$9.56M 78
2023
Q4
$9.56M Buy
+61,011
New +$9.36M 2.55% 14

Other funds holding JNJ

Stempoint Capital's JNJ Position: Q2 2026 in Review

Stempoint Capital sold out of Johnson & Johnson (JNJ) in Q2 2026, closing a stake of 15,415 shares — an estimated $3.77M sold.

Stempoint Capital first reported a position in JNJ in Q4 2023 and held it in 3 quarters. The position peaked at $9.56M in Q4 2023. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Stempoint Capital reported no remaining Johnson & Johnson position as of Q2 2026 after selling out during the quarter.
  • Stempoint Capital sold 15,415 Johnson & Johnson shares in Q2 2026, an estimated $3.77M.
  • Stempoint Capital first reported a position in Johnson & Johnson in Q4 2023 and held it in 3 quarters.
  • Stempoint Capital's Johnson & Johnson position peaked at $9.56M in Q4 2023.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Stempoint Capital's 13F filing for Q2 2026, filed 14 Aug 2026.